These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15944731

  • 1. Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12.
    Chikkanna-Gowda CP, Sheahan BJ, Fleeton MN, Atkins GJ.
    Gene Ther; 2005 Aug; 12(16):1253-63. PubMed ID: 15944731
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice.
    Lyons JA, Sheahan BJ, Galbraith SE, Mehra R, Atkins GJ, Fleeton MN.
    Gene Ther; 2007 Mar; 14(6):503-13. PubMed ID: 17167497
    [Abstract] [Full Text] [Related]

  • 3. Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector.
    Smyth JW, Fleeton MN, Sheahan BJ, Atkins GJ.
    Gene Ther; 2005 Jan; 12(2):147-59. PubMed ID: 15372069
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of murine K-BALB and CT26 tumour growth using a Semliki Forest virus vector with enhanced expression of IL-18.
    Chikkanna-Gowda CP, McNally S, Sheahan BJ, Fleeton MN, Atkins GJ.
    Oncol Rep; 2006 Oct; 16(4):713-9. PubMed ID: 16969484
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas.
    Rodriguez-Madoz JR, Prieto J, Smerdou C.
    Mol Ther; 2005 Jul; 12(1):153-63. PubMed ID: 15963931
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL, Janssen K, Hao Z, Sondel PM, Yang NS.
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [Abstract] [Full Text] [Related]

  • 9. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A, Walczak M, Regts J, Rots MG, Kamps G, Dontje B, Haisma HY, Wilschut J, Daemen T.
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [Abstract] [Full Text] [Related]

  • 10. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO.
    Clin Cancer Res; 2006 Oct 01; 12(19):5859-68. PubMed ID: 17020994
    [Abstract] [Full Text] [Related]

  • 11. Augmentation of alphavirus vector-induced human papilloma virus-specific immune and anti-tumour responses by co-expression of interleukin-12.
    Riezebos-Brilman A, Regts J, Chen M, Wilschut J, Daemen T.
    Vaccine; 2009 Jan 29; 27(5):701-7. PubMed ID: 19041356
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.
    Kramer MG, Masner M, Casales E, Moreno M, Smerdou C, Chabalgoity JA.
    BMC Cancer; 2015 Sep 07; 15():620. PubMed ID: 26347489
    [Abstract] [Full Text] [Related]

  • 13. In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas.
    Shibata MA, Ito Y, Morimoto J, Kusakabe K, Yoshinaka R, Otsuki Y.
    J Gene Med; 2006 Mar 07; 8(3):335-52. PubMed ID: 16345101
    [Abstract] [Full Text] [Related]

  • 14. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
    Kanagawa N, Gao JQ, Motomura Y, Yanagawa T, Mukai Y, Yoshioka Y, Okada N, Nakagawa S.
    Biochem Biophys Res Commun; 2008 Aug 08; 372(4):821-5. PubMed ID: 18519033
    [Abstract] [Full Text] [Related]

  • 15. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A, Stoppacciaro A, Vagliani M, Melani C, Spreafico F, Wysocka M, Parmiani G, Trinchieri G, Colombo MP.
    Eur J Immunol; 1995 Jan 08; 25(1):137-46. PubMed ID: 7843224
    [Abstract] [Full Text] [Related]

  • 16. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL, Smith MJ, Sun BS, Wang GJ, Redmond HP, Wang JH.
    Ann Surg Oncol; 2009 May 08; 16(5):1403-11. PubMed ID: 19263173
    [Abstract] [Full Text] [Related]

  • 17. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.
    Withoff S, Glazenburg KL, van Veen ML, Kraak MM, Hospers GA, Störkel S, de Vries EG, Wilschut J, Daemen T.
    Gene Ther; 2001 Oct 08; 8(20):1515-23. PubMed ID: 11704811
    [Abstract] [Full Text] [Related]

  • 18. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP, Sauter BV, Huang TG, Meseck M, Woo SL, Chen SH.
    Gene Ther; 2005 Oct 08; 12(20):1526-33. PubMed ID: 15973445
    [Abstract] [Full Text] [Related]

  • 19. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography.
    Asselin-Paturel C, Lassau N, Guinebretière JM, Zhang J, Gay F, Bex F, Hallez S, Leclere J, Peronneau P, Mami-Chouaib F, Chouaib S.
    Gene Ther; 1999 Apr 08; 6(4):606-15. PubMed ID: 10476220
    [Abstract] [Full Text] [Related]

  • 20. Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.
    Adris S, Chuluyan E, Bravo A, Berenstein M, Klein S, Jasnis M, Carbone C, Chernajovsky Y, Podhajcer OL.
    Cancer Res; 2000 Dec 01; 60(23):6696-703. PubMed ID: 11118055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.